Can AI Improve Access to Dermatology?
Access to dermatology is not equal. In many regions patients face specialist shortages, long waits, geographic distance, affordability barriers and rising demand. AI cannot solve those problems on its own. What responsible AI and teledermatology may do is extend the reach of the capacity that already exists.
Where the pressure comes from
Dermatology demand has grown faster than dermatology workforces in most healthcare systems. Skin complaints are among the most common reasons people see a primary care clinician, and a substantial share of those consultations end in a referral. Meanwhile the population most at risk of skin cancer — older, sun-exposed, often rural — is exactly the group for whom travel and waiting are hardest.
The result is a two-sided delay: a system-side wait for an appointment, and a patient-side wait before anyone even seeks one. The second delay is the one technology is best placed to shorten.
Where AI may help
Screening
A first-line look at something a person was unsure about, available at any hour and at negligible marginal cost.
Monitoring
Consistent, dated photographic comparison of a specific lesion over weeks or months.
Image capture
Guidance on framing, focus and lighting, which improves the quality of images that later reach a clinician.
Health education
Plain-language explanation of what a change might be, and what makes it worth attention.
Prioritisation support
Helping people understand urgency, which can support — never replace — clinical triage decisions.
Referral navigation
Explaining what the next step looks like locally, and what to bring to the appointment.
Where human care remains essential
Diagnosis
Naming a condition is a clinical act with legal and medical weight.
Physical examination
Texture, elevation, palpation and dermoscopy carry information a photo does not.
Medical history
Context — medication, family history, prior lesions — changes interpretation.
Biopsy
Histopathology remains the reference standard for malignancy.
Treatment
Excision, prescription and follow-up require a responsible clinician.
Clinical judgement
Ambiguity, comorbidity and risk tolerance are human decisions.
A conceptual capacity model
- 1
A large population with skin concerns
Most of whom will never be seen by a dermatologist for a given change.
- 2
Accessible first-line digital screening
Low cost, available on a phone, repeatable without an appointment.
- 3
Low concern → education and monitoring
Guidance on what to watch for, and a structured way to track it over time.
- 4
Potential concern → professional review
Escalation towards a clinician, with better images and better context.
- 5
Healthcare professionals focus on cases needing expertise
Specialist time spent where specialist judgement changes the outcome.
This is a conceptual healthcare-access model, not a description of a clinical triage system. It should not be read as implying that AI determines clinical priority; that decision belongs to healthcare professionals and the services they work in.
ScanSkinAI's approach
ScanSkinAI is exploring this model specifically in skin health: accessible AI-supported screening, structured monitoring, and optional professional review pathways, distributed through the places people already are — home, workplaces, pharmacies, clinics and community programmes. We publish our validation figures rather than describing the technology in the abstract, and we state plainly that the product is a screening tool.
Questions about AI and teledermatology
What is teledermatology?
Teledermatology is the delivery of dermatology care at a distance — typically by sending images and clinical information to a dermatologist for review (store-and-forward), or by live video consultation. It is a way of delivering clinical care, whereas AI-supported screening is a way of helping someone decide whether to seek that care.
Can AI replace a dermatologist?
No. AI models can classify images and flag features, but they do not examine a patient, take a history, use dermoscopy, weigh comorbidities, or perform a biopsy. The realistic role of AI is to widen the front of the funnel so that specialist time is spent where specialist judgement is needed.
How can AI help with dermatology waiting times?
It cannot create clinician capacity. What it may do is reduce avoidable delay at the patient's end — helping someone act on a change sooner — and improve the quality of information that arrives with a referral. Any effect on system-level waiting times depends on how services are designed, not on the model alone.
Is AI skin screening accurate enough to rely on?
ScanSkinAI reports 95.3% concordance with board-certified dermatologists in independent clinical validation and 96.48% benchmark test accuracy on public datasets. Those numbers describe performance in evaluation settings, not a guarantee for an individual image, which is why every result is framed as screening rather than diagnosis.
Medical disclaimer
This page is general information about healthcare access, not medical advice. ScanSkinAI is a screening and wellness-support tool and does not replace diagnosis by a qualified healthcare professional.